Show Summary Details
Page of



Paolo Boffetta

and Carlo La Vecchia

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 January 2022

Neoplasms are a group of diverse diseases with complex distributions in human populations and with different aetiological factors. Current knowledge of the causes of human neoplasms and the development of control strategies have led to the elaboration of lists of recommendations for their prevention. A comprehensive strategy for cancer control might lead to the avoidance of a sizeable proportion of human cancers, and the greatest benefit can be achieved via tobacco control.

Nevertheless, neoplasms will continue to be a major source of human disease and death. Considerable efforts are made in the public and private domains to develop effective therapeutic approaches. Even if major discoveries in the clinical management of cancer patients will be accomplished in the near future, the changes will mainly affect the affluent part of the world population. Prevention of the known causes of cancer remains the most promising approach in reducing the consequences of cancer, in particular in countries with limited resources. Control of tobacco smoking and of smokeless tobacco products, reduced overweight and obesity, moderation in alcohol intake, increased physical activity, avoidance of exposure to solar radiation and control of known occupational carcinogens are the main approaches we currently have to reduce the burden of human neoplasms.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.